The latest data & strategies impacting the development of oncolytic viruses, from virus engineering and biomarker development through to navigating clinical trials
The programme brings together international pharmaceutical organisations, leading biotech companies and globally renowned academic institutions specialising in the development of oncolytic viruses
Full details on the Symposium including the presentations, topic areas and confirmed speakers will be released in the conference brochure in the coming weeks
Registration is now open for the Oncolytic Viruses Symposium. Please click the button below to register for this event.
Our LinkedIn group aims to foster discussion and collaboration between experts working in immunotherapy, autoimmunity and immuno-oncology
Engineering & Translational Strategies To Develop Oncolytic Virus Immunotherapy
Accelerating Oncolytic Virus Immunotherapy To The Clinic
The online Symposium brings together a panel of prominent leaders and scientists, sharing new case studies, innovative data and industry perspectives.
Networking & knowledge-sharing is at the heart of what we do. Alongside the innovative programme, attendees can engage in a variety of event features and make the most of participation in a range of virtual, remote experiences.